Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Akari Therapeutics plc ADR (0.01 USD) (AKTX)
Akari Therapeutics plc ADR (0.01 USD)
XNAS:AKTX
0.3
5.49%

Ask
$0.36 - 210.00
Bid
$0.25 - 1,440.00
Low
$0.28
High
$0.3
Open
$0.29
Prev Close
$0.28
52W High
1.73
52W Low
0.22
Volume
453898
Avg Vol (3m)
620530.4
Float
32484304.45
Chart
TendieTensor AI Analysis

Company
Asset Type: American Depository Receipt Common
SIC Code: 2834
Sector: Health Technology
Industry: Biotechnology
Date Listed: 12/07/2012
Primary Exchange: XNAS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

Phone: (646) 350-0702
Address: 22 Boston Wharf Road
Address 2: Fl 7
City: Boston
State: MA
Postal Code: 02210
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
12
P/E (TTM)
-0.040000
P/B (TTM)
0.404968
Round Lot
100
Composit FIGI
BBG003PMV495
Share Class FIGI
BBG003PMV510
Share Class Shares Outstanding
32.61M
Weighted Shares Outstanding
32.61M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own AKTX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.